Chamath Palihapitiya-led Social Capital invested $4 million in renal disease diagnostics startup Early is Good, the firm tells Axios exclusively.
Why it matters: Bladder cancer is one of the most expensive and commonly diagnosed cancers in the U.S., with roughly 81,100 people expected to be diagnosed this year, yet few tools exist to spot the disease early.
